2-day time International Scientific Symposium features technical advances in stem cell research As the finale of the ESTOOLS task, the consortium partners are holding a major 2-day International Scientific Symposium, and the ultimate Ethics Workshop. The programme includes poster program and gala supper with 6 scientific periods: * Malignancy stem cells * Fate switching and induced pluripotency * Neural stem cells * Neurodegenerative disease modelling & prospects for neural fix * Technological advancements in manipulating pluripotent stem cells * Control of stem cell condition and pluripotency Related StoriesNYSCF, CBR collaborate to customize creation of high-quality stem cell linesSCT, Thermo Fisher Scientific collaborate to advance advancement of cardiac disease modelsNYSCF conference to spotlight translational stem cell and neuroscience research6 additional loudspeakers, one per scientific program, will end up being invited from submitted poster abstracts.We continue to seek strategic partnerships in additional regions. Related StoriesResearchers link organ transplant medication to rise in uncommon lymphomaStudy suggests combination of MMF and CNIs can drive back rare lymphomaStudy may help scientists to better understand complications caused by medication therapy in kidney transplant patients Along with Isotechnika, we are committed to bringing this innovative medicine to China’s approximately 100,000 transplant recipients, a population which keeps growing by about 10,000 new patients each year, stated Dr Jing Lou, CEO of 3SBio.